超声响应的阶段过渡纳米医药可实现强度调节的术后止痛
Xinye Song1, Miao Feng1, Hao Chen2
1Department of Anesthesiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Frontiers in bioengineering and biotechnology
|November 12, 2025
概括
一个新的治疗纳米平台,RDLP,在手术后提供可调节的,超声波触发的疼痛缓解. 这种先进的系统集成成像和药物输送,潜在地减少阿片类药物依赖,改善患者的康复.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 疼痛管理 疼痛管理
背景情况:
- 手术后的疼痛管理面临短期麻醉剂和阿片类药物副作用的挑战.
- 目前的方法缺乏用于缓解疼痛强度的动态调节能力.
研究的目的:
- 开发一个超声波触发,可调节的缓解疼痛的超声波纳米平台 (RDLP).
- 将对比度增强超声波 (CEUS) 成像与受控药物释放相结合.
主要方法:
- RDLP具有核心外结构,具有树突性半孔纳米颗粒 (DMSN) 封装了levobupivacaine和 perfluoropentane (PFP),被Rg3-脂质体覆盖.
- 超声波触发PFP相位过渡,为CEUS成像和药物释放的惯性空心形成微泡.
主要成果:
- 通过超声波的RDLP证明了长时间的止痛和在体内按需的止痛调整.
- 该平台显示了高药物封装效率和加速释放动力学.
- 没有观察到脊髓神经的组织病理损伤,表明良好的生物相容性.
结论:
- 通过结合成像指导和治疗,RDLP提供了一个非侵入性,可调节的术后疼痛管理策略.
- 这个平台有可能减少阿片类药物依赖,并改善患者的治疗结果.
更多相关视频
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
16.4K
08:19Controllable Nucleation of Cavitation from Plasmonic Gold Nanoparticles for Enhancing High Intensity Focused Ultrasound Applications
Published on: October 5, 2018
6.8K
相关概念视频
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
897
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
897
